208 related articles for article (PubMed ID: 32117621)
1. Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study.
Li ZW; Zhang M; Yang YJ; Zhou ZJ; Liu YL; Li H; Bao B; Diao JD; Wang DW
PeerJ; 2020; 8():e8512. PubMed ID: 32117621
[TBL] [Abstract][Full Text] [Related]
2. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
Wang X; Liang N; Tian T; Zhang J; Hu P
Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
[No Abstract] [Full Text] [Related]
3. Postmastectomy radiation therapy for T3N0: a SEER analysis.
Johnson ME; Handorf EA; Martin JM; Hayes SB
Cancer; 2014 Nov; 120(22):3569-74. PubMed ID: 24985911
[TBL] [Abstract][Full Text] [Related]
4. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
5. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
[TBL] [Abstract][Full Text] [Related]
6. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy.
Wang X; Xu Y; Guo S; Zhang J; Abe M; Tan H; Wang S; Chen P; Zong L
Oncol Lett; 2020 Jan; 19(1):735-744. PubMed ID: 31897189
[TBL] [Abstract][Full Text] [Related]
7. A prognostic score model to determine which breast cancer patients with 1-3 positive lymph nodes after modified radical mastectomy should receive radiotherapy.
Chen D; Wang H; Song X; Shi F; Kong L; Yu J
Oncotarget; 2018 Jan; 9(1):385-393. PubMed ID: 29416621
[TBL] [Abstract][Full Text] [Related]
8. Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast: a Surveillance, Epidemiology, and End Results database analysis.
McCammon R; Finlayson C; Schwer A; Rabinovitch R
Cancer; 2008 Aug; 113(4):683-9. PubMed ID: 18543316
[TBL] [Abstract][Full Text] [Related]
9. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
10. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
[TBL] [Abstract][Full Text] [Related]
11. The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease.
Patel M; Li C; Aronson JH; Howie CM; Maraboyina S; Prabhu AV; Kim T
Breast; 2020 Jun; 51():50-56. PubMed ID: 32213441
[TBL] [Abstract][Full Text] [Related]
12. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
Cai W; Zhuang Y; Chen J; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
[TBL] [Abstract][Full Text] [Related]
13. Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.
Abrams MJ; Koffer PP; Wazer DE; Hepel JT
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):384-391. PubMed ID: 28463158
[TBL] [Abstract][Full Text] [Related]
14. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database.
Yan W; Christos P; Nori D; Chao KS; Ravi A
Am J Clin Oncol; 2013 Dec; 36(6):552-7. PubMed ID: 22868241
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
17. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy.
Pu H; Luo Y; Zhang L; Li X; Li F; Chen J; Qian S; Tang Y; Zhao X; Hou L; Gao Y
Front Oncol; 2023; 13():1112687. PubMed ID: 37056328
[TBL] [Abstract][Full Text] [Related]
19. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Zhang WW; Tong Q; Sun JY; Hua X; Long ZQ; Deng JP; Dong Y; Li FY; He ZY; Wu SG; Lin HX
Front Oncol; 2019; 9():270. PubMed ID: 31041190
[No Abstract] [Full Text] [Related]
20. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
